Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

69 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Corrigendum to "Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO)".
De Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, Stella-Ascariz N, Bisbal O, Bermejo-Plaza L, Garcia-Alvarez M, Alejos B, Hernando A, Santacreu-Guerrero M, Cadiñanos J, Mayoral M, Castro JM, Moreno V, Martin-Carbonero L, Delgado R, Rubio R, Pulido F, Arribas JR; ART-PRO, PI16/00837-PI16/00678 study group. De Miguel R, et al. Among authors: cadinanos j. EBioMedicine. 2023 Mar;89:104486. doi: 10.1016/j.ebiom.2023.104486. Epub 2023 Feb 18. EBioMedicine. 2023. PMID: 36806001 Free PMC article. No abstract available.
[Systemic secondary AA amyloidosis].
Cadiñanos J, Costa R, Trujillo D, Real de Asúa D. Cadiñanos J, et al. Med Clin (Barc). 2015 Apr 8;144(7):324-30. doi: 10.1016/j.medcli.2014.05.024. Epub 2014 Jul 11. Med Clin (Barc). 2015. PMID: 25023854 Review. Spanish. No abstract available.
Dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: 48-week results of a non-randomized, pilot clinical trial (ART-PRO).
De Miguel R, Rial-Crestelo D, Dominguez-Dominguez L, Montejano R, Esteban-Cantos A, Aranguren-Rivas P, Stella-Ascariz N, Bisbal O, Bermejo-Plaza L, Garcia-Alvarez M, Alejos B, Hernando A, Santacreu-Guerrero M, Cadiñanos J, Mayoral M, Castro JM, Moreno V, Martin-Carbonero L, Delgado R, Rubio R, Pulido F, Arribas JR; ART-PRO, PI16/00837-PI16/00678 study group. De Miguel R, et al. Among authors: cadinanos j. EBioMedicine. 2020 May;55:102779. doi: 10.1016/j.ebiom.2020.102779. Epub 2020 May 11. EBioMedicine. 2020. PMID: 32408111 Free PMC article. Clinical Trial.
Long-term efficacy of dolutegravir plus lamivudine for maintenance of HIV viral suppression in adults with and without historical resistance to lamivudine: Week 96 results of ART-PRO pilot study.
Rial-Crestelo D, de Miguel R, Montejano R, Dominguez-Dominguez L, Aranguren-Rivas P, Esteban-Cantos A, Bisbal O, Santacreu-Guerrero M, Garcia-Alvarez M, Alejos B, Hernando A, Bermejo-Plaza L, Cadiñanos J, Mayoral M, Castro JM, Moreno V, Martin-Carbonero L, Delgado R, Rubio R, Pulido F, Arribas JR; ART-PRO; PI16/00837-PI16/00678 study group. Rial-Crestelo D, et al. Among authors: cadinanos j. J Antimicrob Chemother. 2021 Feb 11;76(3):738-742. doi: 10.1093/jac/dkaa479. J Antimicrob Chemother. 2021. PMID: 33200210 Clinical Trial.
Epigenetic age acceleration changes 2 years after antiretroviral therapy initiation in adults with HIV: a substudy of the NEAT001/ANRS143 randomised trial.
Esteban-Cantos A, Rodríguez-Centeno J, Barruz P, Alejos B, Saiz-Medrano G, Nevado J, Martin A, Gayá F, De Miguel R, Bernardino JI, Montejano R, Mena-Garay B, Cadiñanos J, Florence E, Mulcahy F, Banhegyi D, Antinori A, Pozniak A, Wallet C, Raffi F, Rodés B, Arribas JR; NEAT001/ANRS143 Study Group. Esteban-Cantos A, et al. Among authors: cadinanos j. Lancet HIV. 2021 Apr;8(4):e197-e205. doi: 10.1016/S2352-3018(21)00006-0. Lancet HIV. 2021. PMID: 33794182
Longitudinal Changes in Epigenetic Age Acceleration in Aviremic Human Immunodeficiency Virus-Infected Recipients of Long-term Antiretroviral Treatment.
Esteban-Cantos A, Montejano R, Rodríguez-Centeno J, Saiz-Medrano G, De Miguel R, Barruz P, Bernardino JI, Mena-Garay B, Cadiñanos J, Jiménez-González M, Nevado J, Valencia E, Mayoral-Muñoz M, Arribas JR, Rodés B. Esteban-Cantos A, et al. Among authors: cadinanos j. J Infect Dis. 2022 Jan 18;225(2):287-294. doi: 10.1093/infdis/jiab338. J Infect Dis. 2022. PMID: 34166509
Detection of archived lamivudine-associated resistance mutations in virologically suppressed, lamivudine-experienced HIV-infected adults by different genotyping techniques (GEN-PRO study).
Montejano R, Dominguez-Dominguez L, de Miguel R, Rial-Crestelo D, Esteban-Cantos A, Aranguren-Rivas P, García-Álvarez M, Alejos B, Bisbal O, Santacreu-Guerrero M, Hernando A, Bermejo-Plaza L, Cadiñanos J, Mayoral M, Castro JM, Moreno V, Martin-Carbonero L, Rodés B, Delgado R, Rubio R, Pulido F, Arribas JR. Montejano R, et al. Among authors: cadinanos j. J Antimicrob Chemother. 2021 Nov 12;76(12):3263-3271. doi: 10.1093/jac/dkab323. J Antimicrob Chemother. 2021. PMID: 34459889
Effects of tenofovir on telomeres, telomerase and T cell maturational subset distribution in long-term aviraemic HIV-infected adults.
Rodríguez-Centeno J, Esteban-Cantos A, Montejano R, Stella-Ascariz N, De Miguel R, Mena-Garay B, Saiz-Medrano G, Alejos B, Jiménez-González M, Bernardino JI, Cadiñanos J, Castro-Alvarez JM, Rodés B, Arribas JR. Rodríguez-Centeno J, et al. Among authors: cadinanos j. J Antimicrob Chemother. 2022 Mar 31;77(4):1125-1132. doi: 10.1093/jac/dkab492. J Antimicrob Chemother. 2022. PMID: 35045162
Ageing with HIV: Challenges and biomarkers.
Rodés B, Cadiñanos J, Esteban-Cantos A, Rodríguez-Centeno J, Arribas JR. Rodés B, et al. Among authors: cadinanos j. EBioMedicine. 2022 Mar;77:103896. doi: 10.1016/j.ebiom.2022.103896. Epub 2022 Feb 25. EBioMedicine. 2022. PMID: 35228014 Free PMC article. Review.
69 results